LYELL IMMUNOPHARMA IN
1.1400
08-October-24 09:44:58
15 minutes delayed
Stocks
+0.0100
+0.88%
Today's range
1.1200 - 1.1698
ISIN
N/A
Source
NASDAQ
-
04 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
24 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in September Investor Conferences
28 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
07 Aug 2024 15:05:01 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
03 Jun 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
07 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
06 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
05 Mar 2024 15:30:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in March Investor Conferences
26 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
09 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
07 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
31 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
11 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Upcoming Investor Conferences
31 Aug 2023 15:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
08 Aug 2023 15:05:01 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
05 Jul 2023 15:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >